Cargando…
Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
Atypical teratoid rhabdoid tumor (AT/RT) is among the most fatal of all pediatric brain tumors. Aside from loss of function mutations in the SMARCB1 (BAF47/INI1/SNF5) chromatin remodeling gene, little is known of other molecular drivers of AT/RT. LIN28A and LIN28B are stem cell factors that regulate...
Autores principales: | Weingart, Melanie F., Roth, Jacquelyn J., Hutt-Cabezas, Marianne, Busse, Tracy M., Kaur, Harpreet, Price, Antoinette, Maynard, Rachael, Rubens, Jeffrey, Taylor, Isabella, Mao, Xing-gang, Xu, Jingying, Kuwahara, Yasumichi, Allen, Sariah J., Erdreich-Epstein, Anat, Weissman, Bernard E., Orr, Brent A., Eberhart, Charles G., Biegel, Jaclyn A., Raabe, Eric H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413645/ https://www.ncbi.nlm.nih.gov/pubmed/25638158 |
Ejemplares similares
-
ATRT-16. THE PI3K INHIBITOR PAXALISIB COMBINES SYNERGISTICALLY WITH THE MEK INHIBITOR MIRDAMETINIB TO TARGET ATYPICAL TERATOID/RHABDOID TUMORS
por: Malebranche, Kristen, et al.
Publicado: (2023) -
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors
por: Casaos, Joshua, et al.
Publicado: (2018) -
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
por: Alva, Elizabeth, et al.
Publicado: (2023) -
ATRT-26. The PI3k inhibitor Paxalisib combines with the novel HDAC1/3 inhibitor RG2833 to improve survival in mice bearing orthotopic xenografts of atypical teratoid/rhabdoid tumors
por: Findlay, Tyler, et al.
Publicado: (2022) -
ATRT-09. COMBINATION OF THE PI3K INHIBITOR PAXALISIB WITH THE NUCLEOSIDE ANALOG GEMCITABINE ACTIVATES THE INTEGRATED STRESS RESPONSE AND EXTENDS SURVIVAL IN ORTHOTOPIC MODELS OF ATYPICAL TERATOID/RHABDOID TUMORS
por: Findlay, Tyler, et al.
Publicado: (2023)